Financial Services

A new drug could redefine life for polycythemia vera patients, replacing frequent, burdensome blood draws with a simple weekly self-injection.

Tango Therapeutics adds seasoned CFO Sung Lee to its board, a strategic move to guide its lead cancer drug, vopimetostat, through late-stage trials.

Scorpio Tankers locks in a five-year, $105M charter deal for two tankers, a strategic move to ensure revenue stability amid a volatile shipping market.

With its blockbuster drug's patent cliff looming, Merck's leadership faces high stakes at the JPM conference to unveil its strategy for future growth.

Mayflower adds BMS Moving & Storage's 16 locations to its network, a key move in parent company UniGroup's 2026 strategy to dominate the moving market.

Ingevity divests its North Charleston CTO assets to Mainstream Pine Products, sharpening its focus on high-margin activated carbon and advanced polymers.

In a major win, Rockwell Medical extends its DaVita supply deal through 2026 with a price hike, underscoring the value of its reliable supply chain.

With Clay Van Doren as new CEO, Avenga signals a major push for global leadership in AI and digital engineering, leveraging his Atos experience.

Paragon Health Institute is leveraging 2025's federal reforms to push free-market policies, targeting Medicaid and setting up a new state-level battle.

Smart scooter giant Niu Technologies posted record annual sales driven by China, but a sharp Q4 drop, especially abroad, clouds its global outlook.

Following a stellar Black Friday, Energizer is expanding its retail footprint and unveiling next-gen chargers at CES, challenging tech accessory giants.

The renewable energy giant is buying back preferred units, a move showcasing its strong liquidity and sharpening its focus on funding future growth.

Douglasville’s Sit Means Sit Atlanta wins a major regional award, recognized for its unique training philosophy that transforms dogs and strengthens families.

Patria Investments' major acquisition of CLO specialist Solis Investimentos signals a new era for private credit in Latin America's evolving market.

Riot Platforms appoints Jason Chung as CFO, consolidating finance and strategy to accelerate its ambitious expansion into digital infrastructure and AI data centers.

The eye health giant has refinanced a massive $2.8B in loans, extending debt maturity and cutting interest costs to bolster its long-term strategy.

Investors eye Aptiv's upcoming Q4 report for clues on its strategy for EV challenges, software delays, and a looming chip shortage in 2026.

The planned exit of a key technology leader sends ripples through Photronics, raising questions about its innovation roadmap despite record financial success.

All eyes are on GH Research ahead of a crucial Jan. 5 announcement on the FDA status of its fast-acting drug for treatment-resistant depression.

A major new partnership is funding research to develop vital diagnostic tests for FTD, aiming to end years-long diagnostic delays for families.